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Objective: To conduct a literature review on the effectiveness of footwear on foot pain, function,
impairment and disability for people with foot and ankle arthritis.
Methods: A search of the electronic databases Scopus, Medline, CINAHL, SportDiscus and the Cochrane
Library was undertaken in September 2017. The key inclusion criteria were studies reporting on ﬁndings
of footwear interventions for people with arthritis with foot pain, function, impairment and/or disability.
The Quality Index Tool was used to assess the methodological quality of studies included in the
qualitative synthesis. The methodological variation of the included studies was assessed to determine the
suitability of meta-analysis and the grading of recommendations, assessment, development and
evaluation (GRADE) system. Between and within group effect sizes were calculated using Cohen’s d.
Results: 1440 studies were identiﬁed for screening with 11 studies included in the review. Mean (range)
quality scores were 67% (39–96%). The majority of studies investigated rheumatoid arthritis
(n ¼ 7), but also included gout (n ¼ 2), and 1st metatarsophalangeal joint osteoarthritis (n ¼ 2).
Meta-analysis and GRADE assessment were not deemed appropriated based on methodological
variation. Footwear interventions included off-the-shelf footwear, therapeutic footwear and therapeutic
footwear with foot orthoses. Key footwear characteristics included cushioning and a wide toe box for
rheumatoid arthritis; cushioning, midsole stability and a rocker-sole for gout; and a rocker-sole for 1st
metatarsophalangeal joint osteoarthritis. Between group effect sizes for outcomes ranged from 0.01 to
1.26. Footwear interventions were associated with reductions in foot pain, impairment and disability for
people with rheumatoid arthritis. Between group differences were more likely to be observed in studies
with shorter follow-up periods in people with rheumatoid arthritis (12 weeks). Footwear interventions
improved foot pain, function and disability in people with gout and foot pain and function in 1st
metatarsophalangeal joint osteoarthritis. Footwear interventions were associated with changes to
plantar pressure in people with rheumatoid arthritis, gout and 1st metatarsophalangeal joint osteo-
arthritis and walking velocity in people with rheumatoid arthritis and gout.
Conclusion: Footwear interventions are associated with reductions in foot pain, impairment and disability
in people with rheumatoid arthritis, improvements to foot pain, function and disability in people with gout
and improvements to foot pain and function in people with 1st metatarsophalangeal joint osteoarthritis.
Footwear interventions have been shown to reduce plantar pressure rheumatoid arthritis, gout and 1st
metatarsophalangeal joint osteoarthritis and improve walking velocity in rheumatoid arthritis and gout.
& 2017 The Authors. Published by Elsevier HS Journals, Inc. This is an open access article under the CC BY-
NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).r HS Journals, Inc. This is an open
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Foot problems are commonly observed by people with foot and
ankle arthritis [1,2]. High levels of foot pain, impairment and
disability are also reported in this population [3,4]. Foot problems
in people with arthritis are also associated with reduced functionaccess article under the CC BY-NC-ND license
M. Frecklington et al. / Seminars in Arthritis and Rheumatism ] (2017) ]]]–]]]2[5] and quality of life [6]. Reduced walking velocity and increased
plantar pressure is also observed in people with arthritis [7]. The
aim of pharmacological and non-pharmacological management of
foot and ankle arthritis is pain reduction, maintenance of function,
accommodation of existing deformity and prevention of further
deformity. Footwear is routinely used as non-pharmacological
intervention [8]. Footwear can include off-the-shelf footwear,
therapeutic footwear and therapeutic footwear combined with a
foot orthosis. People with arthritis affecting the foot and ankle
often use footwear which may contribute to foot pain and
associated disability [9] and describe difﬁculties in ﬁnding suitable
footwear [10]. Current evidence suggests that footwear may offer
beneﬁts for people with foot and ankle arthritis [11–13]. While
there are studies examining the effects of footwear, at this time it
is difﬁcult to appreciate the strength and consistency of exper-
imental work providing support for the utilisation of footwear in
arthritic conditions. Hence, the aim of this review is to evaluate the
evidence for the clinical effectiveness of footwear interventions for
foot pain, function, impairment and disability in people with
arthritis.Methodology
Identiﬁcation of studies
The following electronic databases (CINAHL, MEDLINE, Scopus,
SPORTDiscus and the Cochrane Library) were searched in Septem-
ber 2017, with no limitations were placed on the publication date.
The search strategy comprised of the following keywords: arthri-
tis, rheumatoid arthritis, gout, osteoarthritis, rheumatic disease,
psoriatic arthritis, lupus erythematous, ankylosing spondylitis,
systemic sclerosis, polymyalgia rheumatica with footwear, foot-
wear intervention, foot orthoses, foot orthosis, foot orthotic, insole
and shoe (Supplementary Table 1). The term “footwear interven-
tions” encompasses the use of footwear, footwear with orthoses in
the management of arthritic conditions.
Inclusion/exclusion criteria
Titles and abstracts were screened by a single reviewer (M.F.).
Full-text articles were obtained from selected abstracts and com-
pared against the following inclusion criteria by a single reviewer
(M.F.). Studies were included if they met the following criteria:
being a randomised controlled trial, prospective observational
intervention trials or cross-sectional intervention trials; published
in English; peer-reviewed publications; participants over the age
of 18 years; studies reporting on ﬁndings of footwear interventions
for people with arthritis with foot pain, function (including
temporal-spatial, plantar pressure, kinematic and kinetic data),
impairment and/or disability measured as a primary outcome.
Studies were excluded if: investigated arthritis not affecting the
foot or ankle, case study and case series design, studies reporting
ﬁndings of interventions where footwear was not been stand-
ardised for participants (custom footwear), studies where foot-
wear was used as a control condition for foot orthoses or adapted
for three-dimensional marker placement for foot orthosis inter-
ventions. Off-the-shelf footwear was deﬁned as commercially
available walking and running shoes. Therapeutic footwear was
deﬁned as readymade, orthopaedic-style footwear. Citations of
retrieved publications were examined to obtain further sources.
Data extraction
A standardised form was used to extract publication
details [author(s) and year], study design, participant samplecharacteristics (age gender and participants entered into study),
follow-up period, description of footwear intervention, control/
comparator intervention and outcome measures used to assess
foot pain, function, impairment and disability were recorded.
Assessment of methodological quality
Methodological quality was independently assessed by two
authors (M.F. and M.C.) using the Quality Index Tool [14]. The
Quality Index Tool comprises of 27 items allowing for the assess-
ment of internal validity, external validity, power, analysis and
reporting. Item 27 was adapted to be scored, 0 or 1 based on the
reporting of a powered sample size calculation. Total raw scores
were converted into a percentage. The tool displays high internal
consistency, test–retest reliability and inter-rater reliability [14].
Kappa statistic was used to assess intra-tester agreement between
reviewers. All disagreements in scoring were resolved following
discussion, with a third reviewer (K.R.) consulted if consensus
could not be reached. The methodological variation of the included
studies was assessed to determine the suitability of meta-analysis
and the grading of recommendations, assessment, development
and evaluation (GRADE) system [15]. Between and within group
effect sizes were calculated for the included studies using Cohen’s
d, with effect sizes interpreted as negligible (o0.2), small (≥0.2),
medium (≥0.5) and large (≥0.8) [16].Results
Search results
Following the removal of duplicates, 1440 studies were
screened with 1384 records excluded with 56 full-text records
obtained (Fig.). A further 45 records were excluded. Key reasons
for the exclusion of studies included the use of custom footwear
and the use of footwear as a control condition for 3D gait analysis.
A total of 11 studies met the inclusion criteria for assessment. Of
the included studies, seven investigated rheumatoid arthritis (RA)
[13,17–22], two investigated gout [11,23], and two investigated
ﬁrst metatarsophalangeal joint osteoarthritis (1MTP OA) [12,24].
Five studies were randomised clinical trials [12,13,18,19,21], three
studies were prospective observational intervention studies
[11,17,22] and three studies were laboratory-based intervention
studies [20,23,24].
Methodological quality of studies
The inter-rater agreement between reviewers showed good
agreement (kappa statistic ¼ 0.81). Quality index scores ranged
from 39% to 96% (Table 1). Quality assessment of studies high-
lighted higher bias with respect to blinding of participants and
assessors to treatment allocation, blinding of assessors to main
outcomes, external validity, adjustment for confounding and
reporting adverse events attributed to inventions.
Study characteristics
Study characteristics are displayed in Tables 2–4. A total of 382
participants with arthritis affecting the foot and ankle were
reported, with 218 RA, 92 1MTP OA and 72 participants with gout.
In the gout and RA studies, the majority of participants had well-
established disease duration, but for 1MTP OA the majority had
early disease duration. Follow-up period ranged between 8 and 24
weeks. Meta-analysis and GRADE assessment were not deemed
appropriated based on the variation in disease type, interventions
and tools used to measure primary outcomes. Negligible to large
Table 1
Quality assessment scores of included studies
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27
Moncur and Ward [17] 1 1 1 1 0 1 0 1 1 0 0 0 0 0 0 1 0 0 1 0 1 0 0 0 0 1 0
Fransen and Edmonds [18] 1 1 1 1 1 1 1 0 0 1 0 0 0 0 0 1 1 0 1 1 1 0 1 0 0 1 1
Chalmers et al. [19] 1 1 1 1 1 1 1 1 1 1 0 0 1 0 1 1 1 1 1 1 1 1 1 0 0 1 1
Williams et al. [13] 1 1 1 1 1 1 1 1 1 1 0 0 1 1 0 1 1 1 0 1 1 0 1 1 0 0 1
Hennessy et al. [20] 1 1 1 1 1 1 1 0 na 1 0 0 1 1 0 1 na 1 na 1 1 1 1 1 0 na 1
Cho et al. [21] 1 1 1 1 1 1 1 0 1 1 0 0 1 0 0 0 1 1 0 1 1 1 1 0 0 0 1
Rome et al. [11] 1 1 1 1 1 1 1 1 1 1 0 1 1 1 0 1 1 1 1 1 1 0 1 1 1 1 1
Bagherzadeh Cham et al. [22] 1 1 1 1 1 1 1 0 1 1 0 0 0 0 0 1 1 1 0 1 0 0 0 0 0 1 0
Stewart et al. [23] 1 1 1 1 1 1 1 0 na 1 0 1 1 1 0 1 na 1 na 1 1 0 1 1 1 na 0
Menz et al. [12] 1 1 1 1 2 1 1 1 1 1 1 1 1 0 1 1 1 1 1 1 1 1 1 1 1 1 1
Menz et al. [24] 1 1 1 1 2 1 1 0 na 1 1 1 1 0 0 1 na 1 na 1 1 1 1 1 1 na 0
(1) Study objectives clearly described?
(2) Main outcome measures described in introduction and methods?
(3) Patient characteristics clearly described?
(4) Interventions clearly described?
(5) Distribution of confounders described?
(6) Main study ﬁndings clearly described?
(7) Estimates of random variability in data for main outcomes described?
(8) Adverse events reported?
(9) Characteristics of patients lost to follow-up described?
(10) Conﬁdence intervals and/or actual p values reported?
(11) Subjects asked to participate representative of entire population?
(12) Subjects who agreed to participate representative of entire population?
(13) Staff and facilities representative of treatment patients receive?
(14) Blinding of patients to interventions?
(15) Blinding of assessors measuring main outcomes?
(16) Results based on data dredging made clear?
(17) Adjustment for different lengths of follow-up?
(18) Statistical tests for main outcomes appropriate?
(19) Compliance with intervention reliable?
(20) Main outcome measures accurate (valid and reliable)?
(21) Cases and controls recruited from same population?
(22) Cases and controls recruited over the same period of time?
(23) Patients randomised to intervention groups?
(24) Randomisation concealed from patients and assessors until after recruitment?
(25) Adequate adjustment for confounding?
(26) Losses of patients to follow-up take into account?
(27) Power calculation?
Fig. PRISMA ﬂow diagram of search strategy.
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Table 2
Characteristics of included randomised clinical trials
Author Nos. (% female)
Sample
characteristics,
mean (SD)
Follow-
up
(wk) Intervention Control Outcome measures Findings
Quality
score
Fransen
and
Edmon-
ds [18]
15 RA (80%)
15 Controls
(67%)
• Intervention
group
• Age: 59 (14)
• Disease
duration: 16
(10)
• Control
group
• Age: 60 (9)
• Disease
duration: 15
(12)
8 Extra-depth footwear (P.W. Minor & Son Inc.) Own footwear Primary outcome Not
stated
Between group measures Not reported. 54%
Long inside counter (rear stability and arch
support), foam padded heel counter (leather
lining), soft leather upper, extra depth
(orthoses accommodation)
Outcomes assessed Within group measures
• Lower limb walk
pain, lower limb
stair pain, lower
limb NWB pain
(VAS)
• Function (HAQ)
• Pain-free walk time
(min)
• Temporal-spatial
(normal and fast
walking velocity,
cadence, stride
length)
• Signiﬁcant reduction in lower limb walk pain
(p ¼ 0.001), lower limb stair pain (p ¼ 0.001),
HAQ scores (p ¼ 0.04) with a signiﬁcant increase in
pain-free walk time (p ¼ 0.001) for intervention group
at follow-up. No signiﬁcant differences found in the
control group at follow-up.
• Signiﬁcant improvement (p o 0.05) in normal and fast
walking velocity and stride length for intervention
group at follow-up. No signiﬁcant observed in control
group at follow-up.
Chalmers
et al.
[19]
28 RA (75%) • Total sample
• Age: 60 (10)
• Disease
duration: 15
(9)
12 • Extra-depth footwear
• (P.W. Minor or Drew Co) Firm heel counter,
heel height 1.5–2.0 cm, instep lacing, wide
deep toe box, thick composite sole
• Extra-depth footwear þ soft orthoses
• Firm heel counter, heel height 1.5–2.0 cm,
instep lacing, wide deep toe box, thick
composite sole
• Soft orthoses; 6 mm Plastazote with
medium density 6 mm Plastazote
metatarsal lifts
• Extra-depth footwear þ semi-rigid
orthoses
• Semi-rigid orthoses; NWB cast, 3 mm
Subortholen, RF and FF Nickleplast posting,
FF 3 mm PPT foam, full length leather top
cover
• Primary outcome
MTP pain (VAS)
• Outcomes assessed
• Lower extremity
function (RB, TADL,
50 ft walk time)
Between group measures
• Signiﬁcant improvement in MTP pain scores
(p ¼ 0.006) for footwear and semi-rigid orthoses
group, compared to footwear and soft orthoses group
and footwear alone.
• No signiﬁcant differences in RB, TADL and 50 ft walk
time between groups.
79%
Within group measures
• Signiﬁcant improvement in MTP pain scores
(p ¼ 0.0004) for footwear with semi-rigid orthoses at
follow-up. No signiﬁcant differences in MTP pain with
footwear and Plastazote and footwear only groups at
follow-up.
• No signiﬁcant differences in RB, TADL, and 50 ft walk
time and joint count within groups.
Williams
et al.
[13]
• 40 RA
(73%)
• 40 Controls
(53%)
• Total sample
• Age: not
reported
• Disease
duration: 17
(10)
12 • New therapeutic footwear
• Front of shoe, heel and sole unit, leather
and lining, ease of don/doff, heel height,
sole thickness
• Firm contoured insole
• Traditional
therapeutic
footwear
• Soft, ﬂat 6 mm
Plastazote, 3 mm
Poron insole
• Primary outcomes
• Foot pain, disability,
activity limitation
(FFI)
• Foot pain, foot
function, physical
activity (FHSQ)
Between group measures
• Signiﬁcant improvement in FFI foot pain
(p ¼ 0.02), disability (p ¼ 0.01), limitation
(p ¼ 0.02) and total scores (p ¼ 0.01) for intervention
group compared to control
group at follow-up.
• Signiﬁcant improvement in FHSQ foot pain
(p ¼ 0.00) and foot function (p ¼ 0.00) for
intervention group compared to control group at
follow-up.
71%
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Within group measures
• Signiﬁcant improvement in FFI pain (p ¼ 0.00),
disability (p ¼ 0.00), limitation p ¼ 0.00) and total
scores (p ¼ 0.00) in intervention group at follow-up.
• Signiﬁcant improvement in FHSQ foot pain (p ¼ 0.00),
foot function (p ¼ 0.00) and physical activity scores
(p ¼ 0.02) for intervention group at follow-up.
• No signiﬁcant within group improvement in the
control group at follow-up.
Cho et al.
[21]
22 RA (100%) Intervention
group
24 Extra-depth shoes þ custom orthoses Extra-depth shoes þ
prefabricated
insoles
Primary outcomes Between group measures
• No signiﬁcant differences in foot pain and FFI total
scores between intervention and control group at
follow-up.
61%
Age: 49 (12)
20 Controls
(100%)
• Disease
duration: 8
(6)
• Control
group
• Age: 49 (12)
• Disease
duration: 7
(7)
• Wide toe box, cushioned heel, forefoot
rocker
• Custom orthoses: medial arch support,
medial heel post, metatarsal pad
• Wide toe box,
cushioned heel,
forefoot rocker
• Prefabricated
insole; 6 mm
Plastazote
• Foot pain (VAS)
• Foot pain, disability,
activity limitation
(FFI)
Within group measures
• Signiﬁcant reduction in foot pain (p o 0.05) in
intervention and control groups at follow-up.
Menz
et al.
[12]
• 46 1MTPJ
OA (61%)
• 52 Controls
(44%)
• Intervention
group
• Age: 57 (11)
• Median
disease
duration: 2
• Control
group
• Age: 57(11)
• Median
Disease
duration: 3
12 • Rocker-sole footwear
• (Masai Barefoot Technology (MBT) Mahuta/
Matwa)
• Rounded sole, soft cushioned heel
• Own footwear þ
orthoses
• (Vasyli Customs)
• Full length, cut
out under 1st
metatarsal,
varus wedge
(FPI 4 7)
Primary outcome
Foot pain (FHSQ)
Outcomes assessed
Function (FHSQ) Foot
pain, stiffness,
difﬁculty, activity
limitation,
social issues (FFI-R SF)
1MTP walk pain, 1MTP
rest pain, 1MTP
stiffness (VAS)
Between group measures
• No signiﬁcant differences in foot pain, function,
stiffness, difﬁculty, activity limitation, social issues,
MTP pain and MTP stiffness between groups at
follow-up.
96%
Within group measures
• Not reported.
NWB, non-weightbearing; VAS, visual analogue scale; HAQ, health assessment questionnaire; MTP, metatarsophalangeal joint; RB, Robinson Bashall functional assessment; TADL, Toronto activities of daily living measure; FFI, foot
function index; FHSQ, foot health status questionnaire; FFI-R SF, foot function index—revised (short form); SF, short form.
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Table 3
Characteristics of included prospective observational studies
Author Nos. (% female)
Sample characteristics,
Mean (SD) Follow-up (wk) Intervention Control Outcome measures Findings Quality score
Moncur and Ward
1990 [17]
25 RA (100%) • Age: 57 (not reported)
• Disease duration: not
reported
12 • Heat-mouldable shoes
(Thermold, P.W. Minor Extra
Depth Shoe Co.)
• Extra depth, extra forefoot
width, mouldable Plastomold
lining, pillow top, leather
upper, heat mouldable
No control Primary outcome Not
stated
Between group measures 39%
Not assessed.
Outcomes assessed Within group measures
Walking ability (1–10 Likert
scale)
Signiﬁcant improvement
in walking ability (p o
0.01) at follow-up.
Rome et al. [11] 36 Gout (8%) Age: 57 (13) duration: 15
(11)
8 • Good footwear characteristics
• (ASICS Cardio Zip)
• Leather upper, rubber sole,
dual density midsole, rigid
heel counter, moderate
midfoot sole stability, heel and
forefoot cushioning
• Poor footwear characteristics
• (Dunlop Asteroid) Synthetic
upper, rubber sole, single
density midsole, minimal heel
counter stiffness, minimal
midfoot sole stability, no
cushioning
• (Dunlop Apollo)
• Synthetic upper, synthetic
sole, single density midsole,
minimal heel counter
stiffness, minimal midfoot
sole stability, no cushioning
• (Helix Viper) Synthetic upper,
Phylon sole, single density
midsole, moderate heel
counter stiffness, minimal
midfoot sole stability, heel and
forefoot cushioning
Own footwear • Primary outcome
• Foot pain (VAS)
• Outcomes assessed
• Function (HAQ-II)
• General pain (VAS)
• Lower limb function
(LLTQ)
• Impairment and
disability (LFIS)
• Between group
measures
• Not assessed.
86%
• Within group measures
• Signiﬁcant
improvement in foot
pain (p¼0.002),
general pain
(p¼0.001), HAQ-II
(p¼0.002) and LFIS
impairment subscale
(p¼0.004) observed in
good footwear
characteristics group at
follow-up.
• No signiﬁcant
improvement in poor
footwear
characteristics group at
follow-up.
Bagherzadeh
Cham et al. [22]
18 RA (100%) • Age: 47 (8)
• Disease duration: 8 (7)
4 • Rocker-soled footwear
• High-top, wide toe box,
Velcro, heel-toe rocker
No control • Primary outcome Not
stated
• Outcomes assessed
• Foot pain, disability,
activity limitation (FFI)
• Between group
measures
• Not assessed.
• Within group measures
• Signiﬁcant
improvement in FFI
pain (p ¼ 0.001),
disability (p ¼ 0.044),
activity limitation
(p ¼ 0.04) and total
(p ¼ 0.001) scores at
follow-up.
50%
VAS, visual analogue scale; HAQ, health assessment questionnaire; LLTQ, lower limb tasks questionnaire; LFIS; Leeds foot impact scale; FFI, foot function index.
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Table 4
Characteristics of included lab-based intervention studies
Author Nos. (% female)
Sample characteristics
Mean (SD) Interventions Control Outcome measures Findings
Quality
score
Hennessy
et al.
2007
[20]
20 RA (80%) • Age: 60 (11)
• Disease duration: not
reported
• Running shoe (Brooks Glycerine 3,
Texas Peak Pty Ltd.)
• Commercially available, ‘premium’
cushioned running shoe
• Orthopaedic footwear (P.W. Minor
and Son)
• Extra-depth, cushioning
Control (Dunlop volley)
Sock liner removed, thin
ﬂexible sole
Primary outcome Plantar
pressure (PPP, PTI)
Between group measures 64%
PPP signiﬁcantly reduced at forefoot, rearfoot
and total foot in running shoe (p o 0.001)
and orthopaedic shoe (p o 0.001)
compared to control.
PTI signiﬁcantly reduced at forefoot (p o
0.001), rearfoot (p ¼ 0.008) and total foot
(p o 0.001) with the running shoe
compared to the control. PTI signiﬁcantly
reduced at forefoot (p o 0.001) and total
foot (p o 0.001) with the orthopaedic shoe
compared to the control.
Within group measures Not assessed.
Stewart
et al. [23]
• 21 Gout (5%)
• 15 Gout (13%)
• Good footwear group
• Age: 57(13)
• Disease duration: 13
(8)
• Poor footwear group
• Age: 58 (14)
• Disease duration: 18
(13)
• Good footwear characteristics
• (ASICS Cardio Zip)
• Leather upper, rubber sole, dual
density midsole, rigid heel counter,
moderate midfoot sole stability, heel
and forefoot cushioning
• Poor footwear characteristics
• (Dunlop Asteroid)
• Synthetic upper, rubber sole, single
density midsole, minimal heel
counter stiffness, minimal midfoot
sole stability, no cushioning
• (Dunlop Apollo) Synthetic upper,
synthetic sole, single density
midsole, minimal heel counter
stiffness, minimal midfoot sole
stability, no cushioning
• (Helix Viper)
• Synthetic upper, Phylon sole, single
density midsole, moderate heel
counter stiffness, minimal midfoot
sole stability, heel and forefoot
cushioning
• Between group
• Good footwear
characteristics and
poor footwear
characteristics
• Within group
• Participant’s own
footwear
• Primary outcome Not
stated
• Outcomes assessed
• Plantar pressure (PPP,
PTI)
• Temporal-spatial
(walking velocity, step
length, stride length,
cadence)
Between group measures
• Signiﬁcant decrease in PPP at the medial
heel (p ¼ 0.000) and 5MTP (p ¼ 0.000) in
the good footwear group compared to the
poor footwear group.
• Signiﬁcant decrease in PTI at the heel (p ¼
0.003), lateral heel (p ¼ 0.001) and 5MTP
(p ¼ 0.005) and a signiﬁcant increase in
PTI at the midfoot (p ¼ 0.000) in the good
footwear group compared to the poor
footwear group.
• No signiﬁcant differences in velocity, step
length, stride length or cadence between
groups.
64%
Within group measures
• Signiﬁcant reduction in PPP at 3MTP
(p ¼ 0.003) and 5MTP (p ¼ 0.001).
Decreased PTI at heel (p ¼ 0.000), 3MTP
(p ¼ 0.000) and 5MTP (p ¼ 0.005) and
increased PTI at midfoot (p ¼ 0.000) with
good footwear group compared to control.
• Signiﬁcant reduction in PPP at 3MTP
(p ¼ 0.004) and increased PPP at heel
(p ¼ 0.000) and lesser digits (p ¼ 0.003).
Decreased PTI at midfoot (p ¼ 0.003) in
poor footwear group compared to control.
• Signiﬁcant increase in velocity (p ¼ 0.000),
step length (p ¼ 0.000) and stride length
(p ¼ 0.000) in both intervention groups
compared to control.
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impairment and disability.
Footwear interventions
Footwear interventions included off-the-shelf footwear
[11,12,20,23,24], therapeutic footwear [13,17,18,20,22] and thera-
peutic footwear combined with foot orthoses [19,21].
Off-the-shelf footwear
The use of off-the-shelf footwear was reported in people with
RA [20], gout [11,23] and 1MTP OA [12,24]. In one study in people
with RA, an athletic shoe was used with the footwear character-
istic of this shoe being cushioning for forefoot pain [20]. For people
with gout a range of walking shoes were used and divided into
good footwear characteristics and poor footwear characteristics.
Good footwear characteristics included a rocker-sole to facilitate a
heel-to-toe gait, a dual-density midsole to provide motion control,
heel and forefoot cushioning to improve shock attenuation and a
zip to allow for ease of entry and exit of footwear [11,23]. Poor
footwear characteristics included a single density midsole, no
cushioning, minimal heel counter stiffness and midsole stability
[11,23]. For people with 1MTP OA, a rocker-sole shoe was used,
allowing smoother progression of the body’s centre of mass over
the stance foot, reducing the amount of 1MTP dorsiﬂexion
required and loading at the forefoot joints [12,24].
Therapeutic footwear
The use of therapeutic footwear was reported in ﬁve studies for
people with RA [13,17,18,20,22]. Footwear characteristics included
extra-depth in the forefoot region to accommodate for foot
orthoses and forefoot deformity, soft leather upper and smooth
lining to offer protection, laces, padded heel counter to improve ﬁt
at the heel and a long inside counter to improve rearfoot stability
and arch support [18].
Therapeutic footwear combined with foot orthoses
The use of therapeutic footwear with a foot orthosis was
reported in two studies for people with RA [19,21]. Footwear
characteristics included a wide and deep toe box was used to
accommodate for the foot orthoses. Foot orthoses used in these
studies included semi-rigid and soft devices, manufactured as both
prefabricated and custom.Foot pain
Rheumatoid arthritis
Three RCTs [13,19,21] and one prospective observational study
[22] measured foot pain in people with rheumatoid arthritis. One
RCT [13] compared traditional therapeutic footwear to a newer
therapeutic footwear designed with patient and practitioner input.
After 12 weeks, signiﬁcant between group improvement was
observed for the newer therapeutic footwear group compared to
the traditional therapeutic footwear group (d: 0.92–1.26; large
effect). Signiﬁcant within group improvement in foot pain was
observed in the newer therapeutic footwear group (d: 1.08–1.24;
large effect), with no signiﬁcant improvement in the traditional
therapeutic footwear group (d: 0.18–0.19; negligible effect).
Another RCT [19] compared three footwear conditions; extra-
depth footwear only, extra-depth footwear with soft foot
orthoses and extra-depth footwear with semi-rigid foot orthoses.
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was reported in the extra-depth footwear with semi-rigid
orthoses group compared to the footwear with soft orthoses group
(d ¼ 0.45; medium effect) and footwear only group (d ¼ 0.78;
medium effect). There was no signiﬁcant within group improve-
ment observed in the footwear with soft orthoses and footwear
only groups at 12 weeks. A further RCT [21] compared extra-depth
footwear with semi-rigid foot orthoses compared to extra-depth
footwear with soft orthoses. After 24 weeks, no signiﬁcant differ-
ence was found between groups (d ¼ 0.46; small effect), however,
signiﬁcant within group improvements in foot pain was observed
in the footwear with semi-rigid orthoses group (d ¼ 0.56; medium
effect) and the footwear with soft orthoses group (d ¼ 1.07; large
effect). The prospective observational study [22] reported signiﬁ-
cant within group improvements in foot pain with high-top,
rocker-sole footwear after 4 weeks (d ¼ 1.45; large effect),
however, there was no comparator to this intervention.
Gout
One prospective observational study [11] measured foot pain in
people with gout. One group with good footwear characteristics
was compared to a group with poor footwear characteristics over
an 8-week period. After eight weeks, signiﬁcant within group
improvement in foot pain was observed in the good footwear
characteristics group only (d ¼ 0.75; medium effect). There was no
signiﬁcant improvement in foot pain in the poor footwear char-
acteristics group (d ¼ 0.19; negligible effect).
1MTP OA
One RCT [12] measured foot pain in people with 1MTP OA.
Rocker-sole footwear was compared to the participant’s own foot-
wear with foot orthoses. After 12 weeks, improvements in foot pain
were observed in the rocker-sole footwear group (d ¼ 1.25; large
effect) and own footwear with foot orthoses group (d ¼ 0.95; large
effect), however, no signiﬁcant differences were observed between
groups at follow-up (d ¼ 0.01; negligible effect).Patient-reported outcomes
Patient reported outcome measures assessing function, impair-
ment and disability were reported for RA, gout and 1MTP OA.
Rheumatoid arthritis
One RCT [18] reported a signiﬁcant within group improvement
in function in the extra-depth footwear group with no improve-
ment in the control group at eight weeks. The control group of this
sample were subsequently provided with extra-depth footwear in
a repeated-measures design with signiﬁcant within group
improvements in function at eight weeks (d ¼ 0.30; small effect).
Another RCT [13] reported signiﬁcant between group improve-
ment in foot function, functional limitation and disability in the
new design therapeutic footwear compared to traditional thera-
peutic footwear at 12 weeks (d ¼ 0.88–1.07; large effect).
Signiﬁcant within group improvement was seen in the new design
therapeutic footwear (d ¼ 0.92–1.06; large effect) with non-
signiﬁcant within group improvement in the traditional therapeu-
tic footwear group (d ¼ 0.04–0.33; negligible-small effect). One
RCT [21] comparing therapeutic footwear with soft orthoses and
therapeutic footwear with semi-rigid orthoses reported no sig-
niﬁcant between group differences in activity limitation and
disability at 24 weeks (d ¼ 0.94; large effect). Non-signiﬁcant
within group improvements in activity limitation and disabilitywas observed in the footwear with semi-rigid orthoses group
(d ¼ 0.78; medium effect) and the footwear with soft orthoses
group (d ¼ 1.31; large effect). One prospective observational study
[17] reported a signiﬁcant within group improvement in self-
reported walking ability with heat-mouldable footwear (unable to
calculate effect size). Another prospective observational study [22]
reported within group improvements in foot function, activity
limitation and disability with rocker-sole footwear use at four
weeks (d ¼ 1.03; large effect).
Gout
One prospective observational study [11] measured function, foot-
related impairment and disability. Signiﬁcant improvements in func-
tion (d ¼ 0.44; small effect) and foot-related disability (d ¼ 0.67;
medium effect) were observed in the good footwear characteristics
group, with no signiﬁcant differences observed in the poor footwear
characteristics group at eight weeks (d ¼ 0.14–0.17; negligible effect).
1MTP OA
One RCT [12] measured function. Improvements in foot function
were observed in the rocker-sole footwear group (d ¼ 0.61; medium
effect) and own footwear with foot orthoses group (d ¼ 0.58;
medium effect), however, no signiﬁcant differences were observed
between groups at follow-up (d ¼ 0.04; negligible effect).Plantar pressure and temporal-spatial parameters
Data for plantar pressure and temporal-spatial parameters was
reported for three conditions: RA, gout and 1MTP OA.
Rheumatoid arthritis
One cross-sectional study [20] reported signiﬁcant reductions
in total foot, rearfoot and forefoot peak plantar pressure (PPP) in
the running footwear (d ¼ 1.84, 1.07, 1.78; large effects) and
orthopaedic footwear (d ¼ 0.86, 0.82, 0.84; large effects) groups
compared to the control group. Signiﬁcant reductions in total foot
(d ¼ 1.72, 1.06; large effects) and forefoot pressure (d ¼ 1.74, 1.14;
large effects) time integrals (PTI) in the running footwear and
orthopaedic footwear groups compared to the control group.
Signiﬁcant reductions in rearfoot PTI was observed in the running
footwear group compared to the control group (d ¼ 0.24; small
effect). Signiﬁcant reductions in PPP and PTI for total foot pressure
(d ¼ 1.02, 0.87; large effects) and forefoot pressure (d ¼ 0.91, 0.84;
large effects) in the running footwear group compared to the
orthopaedic footwear group. One RCT [18] reported signiﬁcant
within group increases in walking velocity (d ¼ 0.31; small effect)
and stride length (d ¼ 0.30; small effect) following the provision
of extra-depth footwear compared to the participant’s own shoes
after eight weeks. Another RCT [19] reported no within group or
between group improvements during overground walking, stair
climbing or 50 ft walk time with extra-depth footwear only, extra-
depth footwear with soft orthoses and extra-depth footwear with
semi-rigid orthoses after 12 weeks (d ¼ 0–0.16; negligible effect).
Gout
One cross-sectional study [23] compared good footwear char-
acteristics to poor footwear characteristics to the participant’s own
footwear. Signiﬁcant reductions in PPP and PTI at the heel and
5MTP with increases in midfoot pressure was observed in the good
footwear characteristics group compared to the poor footwear
characteristics footwear group (d ¼ 0.02–0.70; negligible-medium
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5MTP, reductions in PTI at 3MTP, 5MTP and heel with increases in
midfoot PTI was observed in the good footwear characteristics
group compared to their own footwear (d ¼ 0.03–1.11; negligible-
large effect). Signiﬁcant within group increases in PPP at the heel
and lesser toes, reductions at 3MTP and reductions in midfoot PTI
was observed in the poor footwear characteristics group compared
to their own footwear (d ¼ 0.02—0.44; negligible-small effect).
Signiﬁcant within group increases in walking velocity, step length
and stride length in both the good and poor footwear character-
istics groups compared to the participant’s own footwear
(d ¼ 0.16–0.53; negligible-medium effect), however, no between
group differences were observed (d ¼ 0.29; small effect).
1MTP OA
One cross-sectional study [24] reported signiﬁcant within
group reductions in PPP were observed at 1MTP (d ¼ 0.31; small
effect), 2–5MTP (d ¼ 0.91; large effect) and heel (d ¼ 0.90; large
effect) in the rocker-sole footwear group compared to the partic-
ipant’s own footwear. Signiﬁcant reductions in PPP at lesser toes
(d ¼ 0.35; small effect), 2–5MTP (d ¼ 1.12; large effect) and
midfoot (d ¼ 0.72; medium effect) was observed between the
footwear intervention group compared to the own footwear with
orthoses group. A signiﬁcant reduction in stance phase percentage
(d ¼ 0.51; medium effect) in the rocker-sole footwear group compared
to the own footwear with orthoses group. Signiﬁcant within-group
reductions for cadence (d ¼ 0.25; small effect) and stance phase
percentage (d ¼ 0.43; small effect) were observed in the rocker-sole
footwear group compared to the participant’s own footwear.Discussion
The aim of this systematic review was to identify and evaluate
the evidence for the clinical effectiveness of footwear interven-
tions for foot pain, function, impairment and disability in people
with arthritis. Despite the broad search strategy, the search only
identiﬁed studies investigating RA, gout and 1MTP OA. The
ﬁndings of the review support that footwear is associated with
improvements to foot pain, function, impairment and disability in
people with RA. There is evidence to suggest that footwear is
associated with improvements to foot pain, function and disability
in people with gout and improvements to foot pain and function in
people with 1MTP OA. A greater body of evidence exists for RA
compared to gout and OA, and there are no studies of footwear
interventions for other forms of arthritis.
Within and between group effect sizes for foot pain indicate
that footwear interventions are likely to result in improvements to
foot pain in people with arthritis. However, for people with
rheumatoid arthritis there was conﬂicting evidence between
studies as to which type of intervention was preferable. Between
group ﬁndings indicated the majority of studies in favour of
therapeutic footwear with a semi-rigid insole compared to ther-
apeutic footwear with a soft insole on foot pain, however, one
study favoured therapeutic footwear with a soft insole compared
to a semi-rigid insole.
There was considerable variation in the methodology with
respect to the footwear interventions and measures used to assess
both primary and secondary outcomes. Of the included studies,
footwear interventions included footwear only and footwear with
orthoses conditions. It is difﬁcult to isolate the individual treat-
ment effect of footwear and foot orthoses when prescribed
individually or as co-interventions. It is also difﬁcult to ascertain
if the observed changes are related to “the footwear” or speciﬁc
characteristics of the footwear. There is currently no universallyaccepted standard for the measurement of foot pain and self-
reported foot pain intensity is the most frequently used research
tool to measure foot pain [25]. Instruments include visual ana-
logue scales (VAS), numeric rating scales and verbal category/
Likert scale. The complexity of arthritic conditions may advocate
the use of multiple tools to capture the spectrum of foot pain
across a particular condition.
In the RCTs investigating RA, differences between groups was
observed in studies with a shorter follow-up period (from 4 to 12
weeks) compared to studies with a longer follow-up period
(24 weeks). The lack of a control group in the observational studies
for people with RAwas also a limitation. It is difﬁcult to discuss the
inﬂuence of follow-up periods for gout and 1MTP OA as there was
only one longitudinal study for each condition. The description of
footwear interventions ranged from the use of footwear assess-
ment scales, listing desirable footwear characteristics or simply
stating the type of footwear. There was also inconsistency in the
observed changes to outcomes in the control groups in the RA
population. Such variance in the description of footwear and
ﬁndings makes it difﬁcult to determine if changes to the outcomes
are be attributed to “footwear” or speciﬁc footwear characteristics.
Footwear was associated with reductions in plantar pressure in
people with RA, gout and 1MTP OA. The studies included which
investigated plantar pressure all employed a cross-sectional
design, so it is unclear whether these changes are maintained
over time or are associated with improvements to patient reported
outcomes. Footwear was also associated with changes to walking
velocity and stance time. Signiﬁcant reductions in walking velocity
have been found in people with arthritis [7]. Reduced walking
velocity and increased stance time are indicative of foot related-
impairment and disability [26]. A limitation of these ﬁndings is
that their relationship to other parameters such as in-shoe kine-
matics and kinetics is unknown.
When considering footwear for people with RA, key footwear
characteristics associated with improvements to patient reported
outcomes included extra-depth footwear and cushioning.
Adequate toe box volume allows for the accommodation of fore-
foot deformity and foot orthoses. Foot pain associated with fore-
foot deformity [26] and increased forefoot plantar pressure have
been reported people with RA [27]. Footwear with cushioned
midsoles can signiﬁcantly reduce forefoot plantar pressure in
people with RA [20]. The mean disease duration in the included
studies is indicative of participants with established RA. People
with early onset RA may present with different footwear needs.
Footwear characteristics which may be associated with
improvements to foot pain and disability include cushioning and
support for people with gout [11]. These beneﬁts may be related to
changes in plantar pressure and temporal-spatial parameters [23].
Footwear with an absence of cushioning, minimal heel counter
and midsole stability were not associated with improvements to
foot pain in people with gout [11]. Footwear with poor cushioning
and support is common in people with gout and is associated with
higher levels of foot-related impairment and disability [9]. Difﬁ-
culties ﬁnding footwear which ﬁts appropriately, accommodates
existing deformity and is suitable for activities of daily living has
been identiﬁed by people with gout [28–30]. Further investigation
into these domains may help to improve understanding regarding
footwear habits of people with gout.
For people with 1MTP OA, the rocker-sole characteristic of the
footwear was found to reduce loading at the 1MTP and subsequent
improvement in patient reported outcomes. These reductions may
be attributed to reductions in 1–5MTP plantar pressure, cadence
and stance time percentage observed with the rocker-sole foot-
wear compared to participant’s own footwear [24]. Biomechanical
changes have been reported with rocker-sole footwear in both
asymptomatic and symptomatic populations, however, it is
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improved patient-reported outcomes [31].
This review is not without limitations. Pooling of data was not
possible due to the methodological inconsistency between the
included studies, thus recommendations regarding the most
appropriate intervention cannot be made. The search strategy
did not include unpublished literature including theses and confer-
ence proceedings. Differences in the reporting of footwear char-
acteristics made it difﬁcult to draw conclusions regarding the
inﬂuence of speciﬁc design features on patient-reported outcomes
and biomechanical variables. Not all types of footwear have been
tested in clinical studies, and it is unclear whether ﬁndings can be
generalised to other types of footwear which may deliver different
biomechanical effects. As much of the data presented comes from
cross-sectional studies, the long-term effects of footwear on gait
parameters remains unclear.
Future work needs to explore the foot-related problems and
footwear needs of people with other arthritic conditions. Improved
understanding of these conditions may help to determine the role
of footwear interventions in the management of these populations.
The majority of the studies included in this review were for RA
with only one RCT with a follow-up period beyond 12 weeks.
Longitudinal prospective studies and randomised clinical trials
may help to determine the clinical effectiveness of footwear.
Further prospective studies may help to determine if changes to
gait parameters associated with footwear are preserved and
associated with improvements to patient reported outcomes.Conclusion
Footwear interventions are associated with reductions in foot
pain, impairment and disability in people with rheumatoid arthri-
tis, improvements to foot pain, function and disability in people
with gout and improvements to foot pain and function in people
with 1st metatarsophalangeal joint osteoarthritis. Footwear inter-
ventions have been shown to reduce plantar pressure rheumatoid
arthritis, gout and 1st metatarsophalangeal joint osteoarthritis and
improve walking velocity in rheumatoid arthritis and gout.Appendix A. Supporting information
Supplementary data associated with this article can be found in
the online version at http://dx.doi.org/10.1016/j.semarthrit.2017.10.
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